Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Quinoline derivative and application thereof in diabetes

A derivative, quinoline technology, applied in the field of quinoline derivatives and its application in diabetes, can solve the problems of inactivation and short half-life

Inactive Publication Date: 2018-11-30
TONGCHUAN PEOPLES HOSPITAL
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, as the substrate of DPP-4, GLP-1 has a very short half-life and will be rapidly cut and inactivated by DPP-4 within 1-2 minutes after secretion.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Quinoline derivative and application thereof in diabetes
  • Quinoline derivative and application thereof in diabetes
  • Quinoline derivative and application thereof in diabetes

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Example 1: Synthesis of 4-(8-(naphthalene-2-yl)-quinolin-2-yl)-2,6-diisopropylpyridine-3,5-dicarboxylic acid diethyl ester

[0032]

[0033] 1. Synthesis of (Z)-2-((8-bromo-quinolin-2-yl)methylene)-4-methyl-3-oxopentanoic acid ethyl ester

[0034]

[0035] In a 150 mL round bottom flask equipped with a magnetic stirrer, 8-bromo-quinoline-4-carbaldehyde (compound 1) (8.50 g, 36.00 mmol), ethyl 4-methyl-3-oxopentanoate ( Compound 2) (5.70 g, 36.03 mmol), isopropanol (21.1 mL), piperidine (2.2 mL) and glacial acetic acid (1.2 mL). The reaction mixture was stirred at room temperature under nitrogen for 12 hours. The solvent was removed under reduced pressure. The residue was dissolved with dichloromethane (13.88 mL) and washed with saturated NaHCO 3 (3*30mL) solution washed with anhydrous MgSO 4 After drying, remove MgSO by filtration 4 , after concentrating the solvent under reduced pressure, flash column chromatography to obtain off-white solid (Z)-2-((8-bromo-...

Embodiment 2

[0045] Example 2: 4-(8-(4-methyl-naphthalen-2-yl)-quinolin-2-yl)-2,6-diisopropylpyridine-3,5-dicarboxylic acid diethyl ester synthesis

[0046]

[0047] 4-methyl-naphthalene-2-boronic acid (19.60mmol), compound 5 (9.69g, 18.87mmol), Na 2 CO 3 (6.23g, 58.8mmol), DME (31.75mL) and H 2 O (7.83 mL) was added to a 100 mL microwave vial. vial with N 2 Degas for 1 h, then add PdCl 2 (dppf)CH 2 Cl 2 (1.73 g, 2.35 mmol) adduct. The reaction mixture was heated at 120 °C for 2 hours by microwave irradiation. The resulting mixture was diluted with ethyl acetate and filtered through celite, then concentrated in vacuo. Purification by flash chromatography using 0-100% ethyl acetate / heptane as eluent afforded 4-(8-(4-methyl-naphthalen-2-yl)-quinolin-2-yl as an off-white solid )-diethyl 2,6-diisopropylpyridine-3,5-dicarboxylate, 8.57 g, yield 79%. LC-MS (ESI, pos, ion) m / z: 575 [M+H].

Embodiment 3

[0048] Example 3: 4-(8-(4,5 Dimethyl-naphthalen-2-yl)-quinolin-2-yl)-2,6-diisopropylpyridine-3,5-dicarboxylic acid diethyl Synthesis of esters

[0049]

[0050] 4,5 dimethyl-naphthalene-2-boronic acid (19.60mmol), compound 5 (9.69g, 18.87mmol), Na 2 CO 3 (6.23g, 58.8mmol), DME (31.75mL) and H 2 O (7.83 mL) was added to a 100 mL microwave vial. vial with N 2 Degas for 1 h, then add PdCl 2 (dppf)CH 2 Cl 2 (1.73 g, 2.35 mmol) adduct. The reaction mixture was heated at 120 °C for 2 hours by microwave irradiation. The resulting mixture was diluted with ethyl acetate and filtered through celite, then concentrated in vacuo. Purification by flash chromatography using 0-100% ethyl acetate / heptane as eluent afforded 4-(8-(4,5-dimethyl-naphthalen-2-yl)-quinoline-2 as an off-white solid -Diethyl)-2,6-diisopropylpyridine-3,5-dicarboxylate, 8.44 g, yield 76%. LC-MS (ESI, pos, ion) m / z: 589 [M+H].

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a quinoline derivative or pharmacologically acceptable salt shown as a formula I (The formula is shown in the description), wherein R1, R2, R3 and R4 are respectively selectedfrom H or CH3. The compound listed in an in vitro DPP-4 enzyme inhibition test on the inhibition activity of DPP-4 is between Sitagliptin and omarigliptin. The quinoline derivative shown as the formula I disclosed by the invention is a DPP-4 inhibitor with a novel structure type, and the characteristics of the quinoline derivative in pharmacological toxicology and pharmacokinetics deserve more in-depth study, so that drugs used for treating and / or preventing non-insulin-dependent diabetes, hyperglycemia or insulin resistance can be obtained.

Description

technical field [0001] The invention relates to a quinoline derivative and its application in diabetes. Background technique [0002] Diabetes is a disease that seriously threatens human health due to absolute or relative insufficiency of insulin, resulting in elevated blood sugar, which can lead to serious complications and eventually disability or death. There are many kinds of traditional hypoglycemic drugs, mainly divided into insulin sensitizers (such as biguanides, thiazolidinediones, etc.) and insulin secretagogues (such as sulfonylureas and non-sulfonylureas), and so on. But these drugs do not prevent the progression of diabetes, and there are toxic side effects such as weight gain, hypoglycemia, and eventual loss of efficacy. Therefore, it is an urgent task to develop new antidiabetic drugs to prevent or even reverse the deterioration of the disease. [0003] Dipeptidyl peptidase IV (DPP-4) is a glycoprotein widely distributed in the human body. Its function is si...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D401/04A61K31/4709A61P3/10A61P5/50
CPCA61P3/10A61P5/50C07D401/04
Inventor 孟晓旭
Owner TONGCHUAN PEOPLES HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com